Table 1:
Transporter | Interaction Partner | Functional Change?* | Expression Change?* |
---|---|---|---|
NTCP | NTCP | No | N/A |
SOAT | ↓ | ↓ | |
OATP1B1 | OATP1B1 | ↓ | ↓ |
OATP1B3 | OATP1B3 | No | No |
OATP1B1 | N/A | N/A | |
NTCP | N/A | N/A | |
OSTα | OSTβ | Required for function | Required for membrane expression |
OCT1 | OCT1 | No | N/A |
OCT2 | OCT2 | N/A | N/A |
LAPTM4A | N/A | N/A | |
CD63 | N/A | N/A | |
OAT1 | OAT1 | ↓ | ↓ |
OAT3 | OAT3 | N/A | N/A |
Caveolin-1 | ↑ due to gain of protein-cytoskeletal interaction | Redistribution to non-LRD-rich compartments | |
β-actin | |||
Myosin | |||
OCTN2 | Caveolin-1 | N/A | N/A |
Flotillin | N/A | N/A |
Functional and expression change means that the potential changes happened to the target transporter by the interactions with the partner transporters. Arrows represent the increase (↑) or decrease (↓) of function or membrane expression.